Provided by Tiger Trade Technology Pte. Ltd.

Nektar Therapeutics

73.79
-0.2300-0.31%
Volume:241.43K
Turnover:17.50M
Market Cap:2.52B
PE:-11.41
High:74.36
Open:73.01
Low:70.93
Close:74.02
52wk High:109.00
52wk Low:26.45
Shares:34.14M
Float Shares:28.53M
Volume Ratio:0.62
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.4680
EPS(LYR):-9.7254
ROE:-35.75%
ROA:-12.54%
PB:2.79
PE(LYR):-7.59

Loading ...

Earning Preview: Nektar Therapeutics this quarter’s revenue is expected to decrease by 30.74%, and institutional views are bullish

Earnings Agent
·
May 01

Nektar to report first-quarter results after US markets close, host conference call

Reuters
·
Apr 29

BUZZ-Absci rises as brokerage highlights growing opportunity in hair‑loss market

Reuters
·
Apr 28

Nektar Therapeutics announces annual shareholder meeting webcast

Reuters
·
Apr 25

Nektar Therapeutics closes USD 373.8 million follow-on stock offering at USD 92/share

Reuters
·
Apr 24

Nektar Therapeutics : Jefferies Raises Target Price to $150 From $121

THOMSON REUTERS
·
Apr 23

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AT&T, Yesway

Reuters
·
Apr 23

BUZZ-Nektar Therapeutics dips premarket after upsized $325 mln stock sale

Reuters
·
Apr 22

BRIEF-Nektar Therapeutics Announces Pricing Of Upsized $325 Million Public Offering

Reuters
·
Apr 22

Nektar prices upsized USD 325 million follow-on stock offering at USD 92 per share

Reuters
·
Apr 22

Nektar Therapeutics - Sells 3,532,609 Shares at $92.00 per Share

THOMSON REUTERS
·
Apr 22

Nektar Therapeutics Is Maintained at Buy by Citigroup

Dow Jones
·
Apr 22

Stock Track | Nektar Therapeutics Soars 5.58% Intraday on Positive Alopecia Data and Analyst Target Price Hikes

Stock Track
·
Apr 21

Nektar Therapeutics : Wedbush Raises Target Price to $95 From $70

THOMSON REUTERS
·
Apr 21

Nektar price target raised to $151 from $123 at Citi

TIPRANKS
·
Apr 21

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB), Nektar Therapeutics (NKTR) and GE Healthcare Technologies Inc (GEHC)

TIPRANKS
·
Apr 21

BUZZ-Nektar starts $250 mln stock offering after alopecia treatment trial

Reuters
·
Apr 21

BRIEF-Nektar Therapeutics Announces Proposed Public Offering

Reuters
·
Apr 21

Nektar Therapeutics launches underwritten public offering of $250 million common stock

Reuters
·
Apr 21

Nektar Therapeutics - to Use Net Proceeds for R&D, Clinical Development, and General Corporate Purposes

THOMSON REUTERS
·
Apr 21